Sai Parenterals
BSE 544742
5 stories, newest first.
- Acquisition of 60% stake in Prathyak Laboratories R&D facility completed for Rs. 15 crore
- Monitoring agency report flags IPO proceeds deviation up to 10%; no shareholder approval
- Sai Parenterals officials to meet investors/analysts at Hyderabad facilities on 14 October 2026
- Company Secretary resigns; new Company Secretary and Chief Operating Officer appointed
- New Company Secretary and Chief Operating Officer Appointed; CS Resignation Accepted
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.